Skip to Main Content

Author Details

Julian M Hess
Broad Institute of MIT and Harvard
2015
27
21
PMIDPaper TitleJournal TitlePublished Year
36702949Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial.Nat Med2023
36702949Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial.Nat Med2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36624313Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.Nat Med2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36624313Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.Nat Med2023
35398145The Four mRNA Bases Have Quite Different (Un)folding Free Energies, Applications to RNA Splicing and Translation Initiation with BindOligoNet.J Mol Biol2022
35398145The Four mRNA Bases Have Quite Different (Un)folding Free Energies, Applications to RNA Splicing and Translation Initiation with BindOligoNet.J Mol Biol2022
32424350Cas9 activates the p53 pathway and selects for p53-inactivating mutations.Nat Genet2020
32424350Cas9 activates the p53 pathway and selects for p53-inactivating mutations.Nat Genet2020
32587373Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations.Nat Genet2020
32587373Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations.Nat Genet2020
31171663RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues.Science2019
31526759Passenger Hotspot Mutations in Cancer.Cancer Cell2019
31171663RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues.Science2019
31068700Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature2019
31526759Passenger Hotspot Mutations in Cancer.Cancer Cell2019
31068700Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature2019
29316429Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.Cancer Cell2018
30262473Comment on "DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification".Science2018
30107175Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.Cancer Cell2018
30096302Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29955181Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955182Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29625053Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29717118Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.Nat Commun2018
29713087Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29596782Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.Cell Syst2018
29316429Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.Cancer Cell2018
30107175Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.Cancer Cell2018
30096302Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29955181Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955182Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
30262473Comment on "DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification".Science2018
29717118Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.Nat Commun2018
29713087Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29625053Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29596782Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.Cell Syst2018
27869828Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias.Nat Genet2017
28810145Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.Cancer Cell2017
28892075Analysis of somatic microsatellite indels identifies driver events in human tumors.Nat Biotechnol2017
28658632Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28658208Recurrent and functional regulatory mutations in breast cancer.Nature2017
28297679Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
27869828Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias.Nat Genet2017
28297679Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28810145Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.Cancer Cell2017
28658632Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28892075Analysis of somatic microsatellite indels identifies driver events in human tumors.Nat Biotechnol2017
28658208Recurrent and functional regulatory mutations in breast cancer.Nature2017
  • 1 - 50 of 54

Recommended Authors

National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 6
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 8
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 6
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 5
Washington University
Career Start Year 2009
Number of shared co-authors 29
Wellcome Sanger Institute
Career Start Year 2009
Number of shared co-authors 3
University of California San Diego
Career Start Year 2008
Number of shared co-authors 13
University of Oslo
Career Start Year 2007
Number of shared co-authors 6
German Cancer Research Centre DKFZ
Career Start Year 2007
Number of shared co-authors 3
Moores Cancer Center, university of california san diego
Career Start Year 2007
Number of shared co-authors 15
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 12
INSERM U, PSL Research University, Institut Curie Research Center
Career Start Year 2006
Number of shared co-authors 1
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 10
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 34
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 5
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 10
Wellcome Sanger Institute
Career Start Year 2004
Number of shared co-authors 11
University of Augsburg
Career Start Year 2004
Number of shared co-authors 12
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Washington University
Career Start Year 2003
Number of shared co-authors 16
University of California
Career Start Year 2003
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 61
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 6
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 8
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 10
Early Cancer Institute, University of Cambridge
Career Start Year 1999
Number of shared co-authors 3
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 17
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 19

Collaborators

Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 20
Co-authored papers 14
Co-authored papers 13
Broad Institute of MIT and Harvard
Co-authored papers 11
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 7
Baylor College of Medicine
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Broad Institute of MIT and Harvard
Co-authored papers 7
Co-authored papers 7
Broad Institute of Harvard and MIT
Co-authored papers 6
Co-authored papers 6
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 5
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 5
McGill University
Co-authored papers 5
Broad Institute of MIT and Harvard
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Co-authored papers 5
University of California at Santa Cruz
Co-authored papers 5
Broad Institute
Co-authored papers 5
Present address: Dxige Research Inc.
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 4
The Broad Institute of MIT and Harvard
Co-authored papers 4
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Broad Institute
Co-authored papers 4